![Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e3493680-ae6a-47de-9926-af44c83c1f57/gr1.jpg)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives | Hepatic Oncology Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives | Hepatic Oncology](https://www.futuremedicine.com/cms/10.2217/hep.15.43/asset/images/medium/figure1.gif)
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives | Hepatic Oncology
Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival | PLOS ONE
![Liver Transplantation for Hilar Cholangiocarcinoma Mary Douglas, RN, MSN,CCTC Clinical Transplant Coordinator University of Wisconsin- Madison. - ppt download Liver Transplantation for Hilar Cholangiocarcinoma Mary Douglas, RN, MSN,CCTC Clinical Transplant Coordinator University of Wisconsin- Madison. - ppt download](https://images.slideplayer.com/14/4482842/slides/slide_5.jpg)
Liver Transplantation for Hilar Cholangiocarcinoma Mary Douglas, RN, MSN,CCTC Clinical Transplant Coordinator University of Wisconsin- Madison. - ppt download
![PDF) Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival PDF) Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival](https://www.researchgate.net/publication/303872264/figure/fig3/AS:372429064032272@1465805417016/Mayo-clinic-criteria-for-inclusion-in-the-transplantation-protocol-for-hilar_Q320.jpg)
PDF) Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival
![Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41575-020-0310-z/MediaObjects/41575_2020_310_Fig7_HTML.png)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach | HTML Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach | HTML](https://www.mdpi.com/cancers/cancers-14-00362/article_deploy/html/images/cancers-14-00362-g001.png)
Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach | HTML
The Emergence of Liver Transplantation For Hilar Cholangiocarcinoma | PDF | Organ (Anatomy) | Gastroenterology
Mayo Clinic - Cholangiocarcinoma remains a surgical disease, but even with a successful resection the recurrence rate is about 70%. Listen to Dr. Smoot discuss next-generation treatment options. https://mayocl.in/2ZvV0eQ | Facebook
![Living Donor Liver Transplantation for Perihilar Cholangiocarcinoma: Outcomes and Complications - ScienceDirect Living Donor Liver Transplantation for Perihilar Cholangiocarcinoma: Outcomes and Complications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1072751520301277-fx1.jpg)
Living Donor Liver Transplantation for Perihilar Cholangiocarcinoma: Outcomes and Complications - ScienceDirect
![Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers - Gastroenterology Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aff5c054-6050-40e3-91f5-e6a311d7639d/gr1.jpg)